NIH-funded research R01 grant

Neuroimmune control of kidney injury using noninvasive ultrasound

Official title: Neuroimmune Regulation of Acute Kidney Injury

Funded at University of Virginia · NIH-11449889 · Data updated 2026-11-12

A new approach uses targeted ultrasound to gently stimulate nerves and immune signals to help the kidney recover after injury.

More Acute Kidney Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Virginia
NIH-funded
Lab location1 site (Charlottesville, United States)
Project startSeptember 19, 2019
Project endJune 30, 2030
Funding year2026
Award (this year)$806,269
NIH project number2R01DK123248-06A1
Project IDNIH-11449889 on NIH RePORTER

Who could benefit from this research

Could help

Patients with acute kidney injury or at risk for acute kidney damage who could participate in future translational steps or related human studies.

Less likely to help

People without kidney injury or risk factors are unlikely to benefit from this specific mechanistic research.

What this research studies

This project explores how noninvasive pulsed ultrasound can activate nerve pathways that calm inflammation and protect the kidneys in both mice and people. Researchers will test how ultrasound triggers Piezo1 and Piezo2 sensors in immune and nerve cells to reduce acute kidney injury and later scarring. The work builds on prior findings that spleen-targeted ultrasound can prevent kidney injury and will look at the creamy details of the mechanisms and how it might affect the progression to chronic kidney disease. The study aims to translate mechanistic insights into potential new therapies that leverage the body's own anti-inflammatory reflexes.

Why it matters

Potential benefit: If successful, this approach could offer a non-drug therapy to reduce kidney inflammation and injury, potentially limiting progression to chronic kidney disease.

How similar studies have gone: Preliminary data show that spleen-targeted ultrasound can prevent kidney injury in animal models, supporting the potential for translation.

Where this research is happening

  • University of Virginia
    Charlottesville, United States
    Active

Researchers

  • Principal investigator: Okusa, Mark Douglas — University of Virginia
  • Study coordinator: Okusa, Mark Douglas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.